Testing effectiveness (Phase 2)Ended earlyNCT04725812
What this trial is testing
Complement Regulation to Undo Systemic Harm in Preeclampsia
Who this might be right for
PreeclampsiaSevere PreeclampsiaEculizumab+9 more
Cedars-Sinai Medical Center 2
Showing 2 of 2 results